Aarti Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
659.90
10.85 (1.67%)
BSENSE

Jun 18

BSE+NSE Vol: 1.42 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003784,
    "name": "Aarti Pharma",
    "stock_name": "Aarti Pharma",
    "full_name": "Aarti Pharmalabs Ltd",
    "name_url": "stocks-analysis/aarti-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "659.90",
    "chg": 10.85,
    "chgp": "1.67%",
    "dir": 1,
    "prev_price": "649.05",
    "mcapval": "5,944.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543748,
    "symbol": "AARTIPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0LRU01027",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.42 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/aarti-pharma-1003784-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 251,
    "sid": "1003784",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/aarti-pharmalabs-1003784"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "01-Jun-2026",
      "details": "Transcript of Q4 FY 26 Earnings Conference Call.",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results For The Quarter And Financial Year Ended March 31 2026",
      "datetime": "26-May-2026",
      "details": "The Outcome was intimated within the prescribed timelines under various heads however the same was inadvertently missed under Results Tab therefore uploading the same.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "26-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Pharmalabs Ltd has declared <strong>30%</strong> dividend, ex-date: 16 Feb 26",
          "dt": "2026-02-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

01-Jun-2026 | Source : BSE

Transcript of Q4 FY 26 Earnings Conference Call.

Audited Financial Results For The Quarter And Financial Year Ended March 31 2026

26-May-2026 | Source : BSE

The Outcome was intimated within the prescribed timelines under various heads however the same was inadvertently missed under Results Tab therefore uploading the same.

Compliances-Reg.24(A)-Annual Secretarial Compliance

26-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the Financial Year 2025-26

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aarti Pharmalabs Ltd has declared 30% dividend, ex-date: 16 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available